SCHEMBL19863777

SCHEMBL19863777

CC(=O)c1c(-c2ccc(C)cc2)c2cc(Cl)ccc2[nH]c1=O

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 4/20 0.60
MAP2 P11137 5/20 0.57
MEN1 O00255 1/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
KMT2A Q03164 1/20 0.53
IKBKB O14920 1/20 0.52
CHUK O15111 1/20 0.52
AKT1 P31749 1/20 0.52
AKT2 P31751 1/20 0.52
AKT3 Q9Y243 1/20 0.52
ATM Q13315 1/20 0.52
PADI4 Q9UM07 4/20 0.51
KDM4E B2RXH2 1/20 0.49
ROCK2 O75116 1/20 0.49
MAP4K4 O95819 1/20 0.49
LCK P06239 1/20 0.49
PIM1 P11309 1/20 0.49
RPS6KB1 P23443 1/20 0.49
CDK2 P24941 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22899476 0.92 PADI4 (0.57) CSF1RMAP2MEN1KMT2AIKBKB
SCHEMBL19857781 0.89 IKBKB (0.57) CSF1RMAP2IKBKBCHUKAKT1
SCHEMBL6059495 0.88 MAP2 (0.74) CSF1RMAP2IKBKBCHUKAKT1
SCHEMBL30043560 0.88 MAP2 (0.74) CSF1RMAP2IKBKBCHUKAKT1
SCHEMBL23511140 0.86 MAP2 (0.67) CSF1RMAP2ATMPADI4
SCHEMBL19857711 0.86 MAP2 (0.67) CSF1RMAP2MEN1KMT2AATM
SCHEMBL30043961 0.86 MAP2 (0.67) CSF1RMAP2ATMPADI4
SCHEMBL17457314 0.86 CSF1R (0.57) CSF1RMAP2IKBKBCHUKAKT1
SCHEMBL19857834 0.85 MAP2 (0.53) CSF1RMAP2IKBKBCHUKAKT1
SCHEMBL19857829 0.83 CSF1R (0.55) CSF1RMAP2IKBKBCHUKAKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex Sanford Burnham Prebys Medical Discovery Institute 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180044324-A1 Quinolinones as Inhibitors of Translation Initiation Complex EIF4E, EIF4A1, EIF4A2 CSF1R 4194/4885MAP2 998/4885MEN1 3781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.